scholarly journals Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice

2014 ◽  
Vol 1 ◽  
pp. 14023 ◽  
Author(s):  
Mitsuru Ando ◽  
Yuki Takahashi ◽  
Takuma Yamashita ◽  
Mai Fujimoto ◽  
Makiya Nishikawa ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Gene Delivery ◽  
Adverse Events ◽  
Fusion Protein ◽  
Interferon Γ ◽  
Binding Domain ◽  
Heparin Binding ◽  
Domain Fusion ◽  
Heparin Binding Domain

Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5

2000 ◽  
Vol 24 (1) ◽  
pp. 43-51 ◽  
Author(s):  
H Song ◽  
J Beattie ◽  
IW Campbell ◽  
GJ Allan
Keyword(s):  
Binding Site ◽  
Conformational Changes ◽  
Binding Protein ◽  
Binding Activity ◽  
Binding Domain ◽  
Site Directed Mutagenesis ◽  
Heparin Binding ◽  
Igf I ◽  
Heparin Binding Domain ◽  
Igf Binding

Using site-directed mutagenesis, we have undertaken a study of a potential IGF-binding site in the C-terminal domain of rat IGFBP-5, lying close to or within a previously described heparin-binding domain (residues 201-218) in this protein. After analysis of binding activity using three different methods - ligand blotting, solution phase equilibrium binding and biosensor measurement of real-time on- and off-rates - we report that the mutation of two highly conserved residues within this region (glycine 203 and glutamine 209) reduces the affinity of the binding protein for both IGF-I and IGF-II, while having no effect on heparin binding. In addition, we confirm that mutation of basic residues within the heparin-binding domain (R201L, K202E, K206Q and R214A) results in a protein that has attenuated heparin binding but shows only a small reduction in affinity for IGF-I and -II. Previous findings have described the reduction in affinity of IGFBP-5 for IGFs that occurs after complexation of the binding protein with heparin or other components of the extracellular matrix (ECM) and have postulated that such an interaction may result in conformational changes in protein structure, affecting subsequent IGF interaction. Our data suggesting potential overlap of heparin- and IGF-binding domains argue for a more direct effect of ECM modulation of the affinity of IGFBP-5 for ligand by partial occlusion of the IGF-binding site after interaction with ECM.

C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase

2001 ◽  
Vol 360 (1) ◽  
pp. 239-245 ◽  
Author(s):  
Jungyean KIM ◽  
Innoc HAN ◽  
Yeonhee KIM ◽  
Seungin KIM ◽  
Eok-Soo OH
Keyword(s):  
Cell Spreading ◽  
Binding Domain ◽  
Mitogen Activated Protein Kinase ◽  
Heparin Binding ◽  
Cell Binding ◽  
Rat Embryo ◽  
Mapk Activation ◽  
Mitogen Activated Protein ◽  
Heparin Binding Domain ◽  
Cell Binding Domain

Fibronectin (FN) stimulates multiple signalling events including mitogen-activated protein kinase (MAPK) activation. During cell spreading, both the cell-binding domain and the C-terminal heparin-binding domain (HepII) of FN co-operatively regulate cytoskeleton organization. However, in comparison with the large number of studies on the functions of cell-binding domain, there is little information about the role of HepII. We therefore investigated the effect of HepII on integrin-mediated cell spreading and adhesion on FN and MAPK activation. In contrast with cells on FN substrates, rat embryo fibroblasts on FN120, which lacks HepII, were less spread, had weaker adhesion to FN and failed to form focal adhesions and actin stress fibres. Phosphotyrosine was present in the focal contacts of rat embryo fibroblasts on FN within 30min but was absent from cells on FN120. Overall, tyrosine phosphorylation was much less in cell lysates from cells on FN120, with decreased phosphorylation of focal adhesion kinase (‘pp125FAK’) on tyrosine-397, implying additional regulation of tyrosine phosphorylation by HepII. Nevertheless, adhesion-mediated MAPK activity was similar in cells on FN and on FN120. Furthermore, cells spread on FN and on FN120 substrates showed similar MAPK activation in response to treatment with epidermal growth factor and with platelet-derived growth factor. Consistently, overexpression of syndecan-4, which binds to HepII, enhanced cell spreading and adhesion on FN but did not affect integrin-mediated MAPK activation. We therefore conclude that both HepII and syndecan-4 regulate integrin-mediated cell spreading but not MAPK activation.

scholarly journals Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

10.3791/54202 ◽  
2016 ◽  
Author(s):  
Raymond Wing Moon Lam ◽  
Sunny Akogwu Abbah ◽  
Wang Ming ◽  
Mathanapriya Naidu ◽  
Felly Ng ◽  
...  
Keyword(s):  
Growth Factor ◽  
Polyelectrolyte Complex ◽  
Binding Domain ◽  
Growth Factor Delivery ◽  
Heparin Binding ◽  
Heparin Binding Domain

scholarly journals Role of the heparin-binding domain in intracellular trafficking of sHB-EGF

2019 ◽  
Vol 91 (4) ◽  
pp. 26-32
Author(s):  
O. I. Krynina ◽  
◽  
K. Yu. Manoilov ◽  
D. V. Kolybo ◽  
S. V. Komisarenko ◽  
...  
Keyword(s):  
Intracellular Trafficking ◽  
Binding Domain ◽  
Heparin Binding ◽  
Heparin Binding Domain

The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis

Biomaterials ◽  
2010 ◽  
Vol 31 (28) ◽  
pp. 7226-7238 ◽  
Author(s):  
Yoon Jung Choi ◽  
Jue Yeon Lee ◽  
Jung Hyun Park ◽  
Jun Beom Park ◽  
Jin Sook Suh ◽  
...  
Keyword(s):  
Bone Morphogenetic Protein ◽  
Binding Domain ◽  
Bone Morphogenetic Protein 4 ◽  
Heparin Binding ◽  
Morphogenetic Protein ◽  
Heparin Binding Domain ◽  
Domain Peptide
Sign in / Sign up

Export Citation Format

Share Document